GENEDRIVE PLC Logo

GENEDRIVE PLC

Develops rapid, point-of-care pharmacogenetic testing platforms for personalized medicine.

GDR | IL

Overview

Corporate Details

ISIN(s):
GB00B1VKB244 (+2 more)
LEI:
213800ZYODIRZ87Y4K14
Country:
United Kingdom
Address:
THE INCUBATOR BUILDING, M13 9XX MANCHESTER

Description

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-11 10:10
New interactive investor hub
English 13.8 KB
2025-12-09 17:00
Agreement of Shareholder Loan
English 16.9 KB
2025-12-08 17:10
Annual Report and Accounts and date of AGM
English 13.1 KB
2025-12-05 08:20
Final Results
English 215.8 KB
2025-12-03 08:35
Notice of Results
English 13.7 KB
2025-12-01 16:30
Block Listing Returns
English 24.2 KB
2025-12-01 08:40
Results presented re. NHS CYP2C19 Genotype Testing
English 20.0 KB
2025-11-27 11:20
NHS implementation guide published for CYP2C19
English 16.9 KB
2025-11-26 08:25
Scotland national roll-out of MT-RNR1 ID Kit
English 15.3 KB
2025-11-19 08:25
Further re Shareholder Loan
English 17.3 KB
2025-11-04 08:30
MT-RNR1 ID Kit in Dublin’s Rotunda Hospital
English 14.8 KB
2025-10-31 08:00
Potential Shareholder Loan
English 13.2 KB
2025-10-24 17:30
Application for Listing & Total Voting Rights
English 12.6 KB
2025-10-10 14:32
Holding(s) in Company
English 52.5 KB
2025-10-10 14:31
Holding(s) in Company
English 23.9 KB

Automate Your Workflow. Get a real-time feed of all GENEDRIVE PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENEDRIVE PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENEDRIVE PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.